These data indicate that higher Foxp3+ Treg inhibitory activity reflects the restoration of peripheral T cell tolerance in patients with active RA, suggesting Treg suppressive function in vitro as a prognostic marker of RA disease activity. The gene discussed is FOXP3; the disease is rheumatoid arthritis.